Redeye Feed

2025-04-16 14:22:00 Alzinova - Leverage through strengthened cash position

2025-04-15 14:17:00 Q-linea - Improved commercial momentum

2025-04-15 13:48:00 Faron Pharmaceuticals - Positive phase II BEXMAB topline results

2025-04-15 10:44:00 CoinShares Q1 2025 Preview - Oversold on price action

2025-04-14 16:08:00 Carasent - AI initiatives in focus

2025-04-11 19:52:00 Episurf Medical Q1 2025 - Solid start of 2025

2025-04-10 18:27:00 IRLAB - Missed top line readout with Pirepemat, detailed data indicate potential way forward

2025-04-10 18:25:00 Ependion - Welotec – a good strategic fit

2025-04-09 08:21:00 XVIVO - Enters 2025 in white waters

2025-04-09 07:49:00 Transtema Q1 Preview - Nordic exposure in favour

2025-04-03 08:12:00 Redeye Initiates Coverage of Tradedoubler

2025-04-01 10:29:00 Flexion Mobile - Climbing in the value chain

2025-04-01 10:27:00 Physitrack - Divestment of Wellnow

2025-04-01 10:25:00 Addnode Q1 Preview - Minor revisions – Relatively low valuation

2025-03-31 08:26:00 Freemelt - Strong start to 2025

2025-03-31 08:25:00 Lipigon Q4 2024 - Rights issue funds 2025

2025-03-27 13:28:00 Magle Chemoswed Q4 - Delivering on its growth trajectory

2025-03-27 09:28:00 Xbrane Biopharma - A new beginning?

2025-03-27 09:27:00 Redeye Initiates Coverage of Lime Technologies

2025-03-26 11:39:00 Waystream - Estimate revisions ahead of Q1 2025

2025-03-25 18:46:00 GomSpace - Changes After Directed Share Issue

2025-03-24 10:27:00 Paxman - From a duopoly to a monopoly

2025-03-24 10:25:00 Vitrolife - Enters 2025 fighting

2025-03-24 10:24:00 Redeye Initiates Coverage of Momentum Group

2025-03-14 09:03:00 Biovica - Expanding market reach and increased sales

2025-03-12 09:05:00 Redeye Initiates Coverage of RaySearch Laboratories

2025-03-10 08:58:00 AlzeCure Q4 2024 - A boost from Brussels

2025-03-10 08:57:00 Maximum Entertainment - Strong cost control

2025-03-10 08:56:00 Systemair - Back on the growth track

2025-03-06 12:42:00 BrightBid - Global Growth Initiatives and Cost Cuts

2025-03-05 07:29:00 Ngenic - 2025 should be a comeback year

2025-03-05 07:28:00 Dala Energi - Trading below book value with an improved business model

2025-03-04 18:45:00 Scandinavian ChemoTech - Continued growth in recurring revenues

2025-03-04 18:44:00 BioInvent Q4 2024 - January Readout an Anticlimax

2025-03-04 18:43:00 Integrum Q3 - Entering the first quarter of the strategic shift

2025-03-04 18:18:00 Northbaze Group - Challenging market conditions at year-end

2025-03-04 18:17:00 Heliospectra - Commercial expansion with a ready product portfolio – Set for 2025

2025-03-04 18:16:00 Redeye initiates coverage of GomSpace

2025-03-04 18:13:00 OXE Marine - Ready to rev up

2025-03-03 17:50:00 Saniona Q4 - Strengthened position

2025-03-03 17:49:00 Oncopeptides Q4 - Germany Drives Sales

2025-03-03 17:47:00 Q-linea Q4 - Several commercial steps in the right direction

2025-03-03 08:05:00 Jumpgate Q4 2024 - Soft sales and divestment of Tableflip Entertainment

2025-03-03 07:55:00 MindArk - Soft quarter but balance sheet remains intact

2025-03-03 07:54:00 Physitrack - Strong Finish to the Year, well positioned for 2025

2025-03-03 07:52:00 Redeye Initiates Coverage of GiG Software

2025-02-28 17:38:00 Klaria Pharma Q4 - Transforming licensing deal

2025-02-28 17:36:00 Initiator Pharma Q4 - Awaiting a licensing deal

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden